Boswellia sacra Flueck. Oleo-gum-resin Nanophytosome: Development, Standardization, and Cholinesterase Inhibitory Potential
Open Access
- 9 August 2026
- journal article
- Published by Brieflands in Jundishapur Journal of Natural Pharmaceutical Products
- Vol. 21 (3) , e171846
Abstract
Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder associated with cholinergic dysfunction. The limited efficacy of current acetylcholinesterase inhibitors underscores the need for novel therapeutic approaches. Objectives: This study evaluated the acetylcholinesterase inhibitory activity of Boswellia sacra extracts and their phytosomal formulations. Methods: The methanolic extract of B. sacra was fractionated using potassium hydroxide (KOH) and ethyl acetate to obtain a boswellic acid-enriched fraction, which was further purified by silica gel chromatography to yield two derivatives identified by 1H and 13C nuclear magnetic resonance (NMR) spectroscopy. A phytosomal formulation was prepared using soy lecithin and cholesterol via high-shear homogenization followed by ultrasonication. The optimized nanophytosome was characterized by dynamic light scattering (DLS), Fourier transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC), transmission electron microscopy (TEM), and scanning electron microscopy (SEM). Entrapment efficiency, stability, the in vivo release profile, cholinesterase inhibitory activity was assessed using Ellman’s method. Results: Phytochemical analysis yielded 3-acetyl-11-keto-boswellic acid (1) and 11-keto-boswellic acid (2), and compound 1 was used for standardization. The optimized phytosome exhibited a mean particle size of 112 ± 12.28 nm, a polydispersity index (PDI) of 0.23 ± 0.1, a zeta potential of -53 ± 5.87 mV, and an entrapment efficiency of 75.3 ± 1.47%. FTIR and DSC confirmed molecular interactions between lecithin and the extract, whereas TEM and SEM revealed spherical morphology. The optimized phytosomal formulation demonstrated a gradual release profile, reaching 92% after 12 hours, and increased acetylcholinesterase inhibition to 61.0 ± 10.7% (half-maximal inhibitory concentration [IC50], 177.9 ± 26.8 µg/mL) compared with the non-formulated extract. It also showed moderate butyrylcholinesterase inhibition (42 - 48%) and selectivity for acetylcholinesterase inhibition. Conclusions: The optimized phytosomal formulation enhanced in vitro acetylcholinesterase inhibitory activity compared with the non-formulated extract, indicating the potential of this delivery system to improve the biological activity of Boswellia constituents in cell-free enzyme assays. However, these findings are preliminary and limited to in vitro experiments. Further studies are required to assess blood–brain barrier permeability, neuronal uptake, pharmacokinetics, and in vivo therapeutic efficacy.Keywords
This publication has 42 references indexed in Scilit:
- Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's diseaseEuropean Journal of Medicinal Chemistry Reports, 2024
- Nanocarriers based novel and effective drug delivery systemInternational Journal of Pharmaceutics, 2022
- The Biological Activity of 3-O-Acetyl-11-keto-β-Boswellic Acid in Nervous System DiseasesNeuroMolecular Medicine, 2022
- Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderlyInflammopharmacology, 2021
- Interaction of Nanomaterials with Biological Systems2021
- Phyto-phospholipid complexes (phytosomes): A novel strategy to improve the bioavailability of active constituentsAsian Journal of Pharmaceutical Sciences, 2019
- Phase behaviour of dehydrated phosphatidylcholinesJournal of Thermal Analysis and Calorimetry, 2016
- Synthesis and evaluation of novel oxoisoindoline derivatives as acetylcholinesterase inhibitorsMonatshefte für Chemie - Chemical Monthly, 2014
- Evaluation of systemic administration of Boswellia papyrifera extracts on spatial memory retention in male ratsJournal of Natural Medicines, 2011
- An Efficient Method for the Large‐Scale Preparation of 3‐O‐Acetyl‐11‐oxo‐β‐boswellic Acid and Other Boswellic AcidsEuropean Journal of Organic Chemistry, 2003